Polyphenols with antiglycation activity and mechanisms of action: A review of recent findings

Journal of Food and Drug Analysis

Volumn 25, Issue 1, 2017, Pages 84-92

  Yeh, Wan Ju ^a   Hsia, Shih Min ^a   Lee, Wei Hwa ^b   Wu, Chi Hao ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

advanced glycation end products; antiglycation; flavonoid; phenolic acid; polyphenols

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CARBONYL DERIVATIVE; FLAVONOID; LIGNAN; METHYLGLYOXAL; POLYPHENOL; STILBENE DERIVATIVE; FREE RADICAL;

ANTIOXIDANT ACTIVITY; DETOXIFICATION; DRUG MECHANISM; GLYCATION; HUMAN; IN VIVO STUDY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; CHEMISTRY; OXIDATIVE STRESS;

FREE RADICALS; GLYCATION END PRODUCTS, ADVANCED; OXIDATIVE STRESS; POLYPHENOLS; PYRUVALDEHYDE;

EID: 85009247776     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2016.10.017     Document Type: Review

References (72)

1. [1] Maillard, L.C., Formation of Melanoidins in a Methodical Way. Compt Rend 154 (1912), 66–68.
2. [2] Peppa, M., Vlassara, H., Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens) 4 (2005), 28–37.
3. [3] Yeh, W.J., Yang, H.Y., Pai, M.H., Wu, C.H., Chen, J.R., Long-term administration of advanced glycation end product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury. J Nutr Biochem 39 (2016), 68–76.
4. [4] Lin, J.A., Wu, C.H., Lu, C.C., Hsia, S.M., Yen, G.C., Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression. Mol Nutr Food Res 60 (2016), 1850–1864.
5. [5] Singh, R., Barden, A., Mori, T., Beilin, L., Advanced glycation end-products: a review. Diabetologia 44 (2001), 129–146.
6. [6] Nagaraj, R.H., Sarkar, P., Mally, A., Biemel, K.M., Lederer, M.O., Padayatti, P.S., Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch Biochem Biophys 402 (2002), 110–119.
7. [7] Rabbani, N., Xue, M., Thornalley, P.J., Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments. Clin Sci 130 (2016), 1677–1696.
8. [8] Lapolla, A., Flamini, R., Dalla Vedova, A., Senesi, A., Reitano, R., Fedele, D., Basso, E., Seraglia, R., Traldi, P., Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med 41 (2003), 1166–1173.
9. [9] Kumagai, T., Nangaku, M., Kojima, I., Nagai, R., Ingelfinger, J.R., Miyata, T., Fujita, T., Inagi, R., Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 296 (2009), F912–F921.
10. [10] Van Puyvelde, K., Mets, T., Njemini, R., Beyer, I., Bautmans, I., Effect of advanced glycation end product intake on inflammation and aging: a systematic review. Nutr Rev 72 (2014), 638–650.
11. [11] Tan, D., Wang, Y., Lo, C.Y., Ho, C.T., Methylglyoxal: its presence and potential scavengers. Asia Pac J Clin Nutr 17:Suppl 1 (2008), 261–264.
12. [12] Chen, H., Virk, M.S., Chen, F., Phenolic acids inhibit the formation of advanced glycation end products in food simulation systems depending on their reducing powers and structures. Int J Food Sci Nutr 67 (2016), 400–411.
13. [13] Bonnefont-Rousselot, D., Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5 (2002), 561–568.
14. [14] Kalapos, M.P., Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 110 (1999), 145–175.
15. [15] Rabbani, N., Thornalley, P.J., Dicarbonyl proteome and genome damage in metabolic and vascular disease. Biochem Soc Trans 42 (2014), 425–432.
16. [16] Nemet, I., Varga-Defterdarović, L., Turk, Z., Methylglyoxal in food and living organisms. Mol Nutr Food Res 50 (2006), 1105–1117.
17. [17] Homoki-Farkas, P., Orsi, F., Kroh, L.W., Methylglyoxal determination from different carbohydrates during heat processin. Food Chem 59 (1997), 157–163.
18. [18] Hollnagel, A., Kroh, L.Z., Formation of α-dicarbonyl fragments from mono- and disaccharides under caramelization and Maillard reaction conditions. Eur Food Res Technol 207 (1998), 50–54.
19. [19] de Revel, G., Pripis-Nicolau, L., Barbe, J.C., Bertrand, A., The detection of α-dicarbonyl compounds in wine by formation of quinoxaline derivatives. J Sci Food Agric 80 (2000), 102–108.
20. [20] Yadav, S.K., Singla-Pareek, S.L., Ray, M., Reddy, M.K., Sopory, S.K., Methylglyoxal levels in plants under salinity stress are dependent on glyoxalase I and glutathione. Biochem Biophys Res Commun 337 (2005), 61–67.
21. [21] Golej, J., Hoeger, H., Radner, W., Unfried, G., Lubec, G., Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci 63 (1998), 801–807.
22. [22] Bohlender, J.M., Franke, S., Stein, G., Wolf, G., Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 289 (2005), F645–F659.
23. [23] Pompliano, D.L., Peyman, A., Knowles, J.R., Stabilization of a reaction intermediate as a catalytic device: definition of the functional role of the flexible loop in triosephosphate isomerase. Biochemistry 29 (1990), 3186–3194.
24. [24] Richard, J.P., Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans 21 (1993), 549–553.
25. [25] Wang, X., Desai, K., Clausen, J.T., Wu, L., Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. Kidney Int 66 (2004), 2315–2321.
26. [26] Ruggenenti, P., Flores, C., Aros, C., Ene-Iordache, B., Trevisan, R., Ottomano, C., Remuzzi, G., Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy. Diabetes Care 26 (2003), 502–509.
27. [27] Zieman, S., Kass, D., Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail 10 (2004), 144–149 quiz 150–1.
28. [28] Rabbani, N., Xue, M., Thornalley, P.J., Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. Glycoconj J 33 (2016), 513–525.
29. [29] Shinohara, M., Thornalley, P.J., Giardino, I., Beisswenger, P., Thorpe, S.R., Onorato, J., Brownlee, M., Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101 (1998), 1142–1147.
30. [30] Xue, M., Weickert, M.O., Qureshi, S., Kandala, N.B., Anwar, A., Waldron, M., Shafie, A., Messenger, D., Fowler, M., Jenkins, G., Rabbani, N., Thornalley, P.J., Improved Glycemic Control and Vascular Function in Overweight and obese subjects by glyoxalase 1 inducer formulation. Diabetes 65 (2016), 2282–2294.
31. [31] Xiao, J.B., Hogger, P., Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem 22 (2015), 23–38.
32. [32] Choudhury, R., Srai, S.K., Debnam, E., Rice-Evans, C.A., Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic Biol Med 27 (1999), 278–286.
33. [33] Wu, C.H., Yeh, C.T., Shih, P.H., Yen, G.C., Dietary phenolic acids attenuate multiple stages of protein glycation and high-glucose-stimulated proinflammatory IL-1beta activation by interfering with chromatin remodeling and transcription in monocytes. Mol Nutr Food Res 54:Suppl 2 (2010), S127–S140.
34. [34] Lo, C.Y., Hsiao, W.T., Chen, X.Y., Efficiency of trapping methylglyoxal by phenols and phenolic acids. J Food Sci 76 (2011), H90–H96.
35. [35] Wu, C.H., Yen, G.C., Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 53 (2005), 3167–3173.
36. [36] Srey, C., Hull, G.L., Connolly, L., Elliott, C.T., del Castillo, M.D., Ames, J.M., Effect of inhibitor compounds on Nepsilon-(carboxymethyl)lysine (CML) and Nepsilon-(carboxyethyl)lysine (CEL) formation in model foods. J Agric Food Chem 58 (2010), 12036–12041.
37. [37] Silvan, J.M., Assar, S.H., Srey, C., Dolores Del Castillo, M., Ames, J.M., Control of the Maillard reaction by ferulic acid. Food Chem 128 (2011), 208–213.
38. [38] Umadevi, S., Gopi, V., Vellaichamy, E., Inhibitory effect of gallic acid on advanced glycation end products induced up-regulation of inflammatory cytokines and matrix proteins in H9C2 (2-1) cells. Cardiovasc Toxicol 13 (2013), 396–405.
39. [39] Umadevi, S., Gopi, V., Elangovan, V., Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats. Chem Biol Interact 208 (2014), 28–36.
40. [40] Fernandez-Gomez, B., Ullate, M., Picariello, G., Ferranti, P., Mesa, M.D., del Castillo, M.D., New knowledge on the antiglycoxidative mechanism of chlorogenic acid. Food Funct 6 (2015), 2081–2090.
41. [41] Muthenna, P., Akileshwari, C., Reddy, G.B., Ellagic acid, a new antiglycating agent: its inhibition of N-(carboxymethyl)lysine. Biochem J 442 (2012), 221–230.
42. [42] Sadowska-Bartosz, I., Galiniak, S., Bartosz, G., Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components. Molecules 19 (2014), 18828–18849.
43. [43] Chao, C.Y., Mong, M.C., Chan, K.C., Yin, M.C., Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 54 (2010), 388–395.
44. [44] Wu, C.H., Huang, H.W., Lin, J.A., Huang, S.M., Yen, G.C., The proglycation effect of caffeic acid leads to the elevation of oxidative stress and inflammation in monocytes, macrophages and vascular endothelial cells. J Nutr Biochem 22 (2011), 585–594.
45. [45] Kiso, Y., Antioxidative roles of sesamin, a functional lignan in sesame seed, and it's effect on lipid- and alcohol-metabolism in the liver: a DNA microarray study. Biofactors 21 (2004), 191–196.
46. [46] Kong, X., Yang, J.R., Guo, L.Q., Xiong, Y., Wu, X.Q., Huang, K., Zhou, Y., Sesamin improves endothelial dysfunction in renovascular hypertensive rats fed with a high-fat, high-sucrose diet. Eur J Pharmacol 620 (2009), 84–89.
47. [47] Kong, X., Wang, G.D., Ma, M.Z., Deng, R.Y., Guo, L.Q., Zhang, J.X., Yang, J.R., Su, Q., Sesamin ameliorates advanced glycation end products-induced pancreatic beta-cell dysfunction and apoptosis. Nutrients 7 (2015), 4689–4704.
48. [48] Ribas, S.A., Grando, R.L., Zago, L., Carvajal, E., Fierro, I.M., Overview of flaxseed patent applications for the reduction of cholesterol levels. Recent Pat Food Nutr Agric, 8, 2016, 10.2174/2212798408666160321124149.
49. [49] Ren, G.Y., Chen, C.Y., Chen, G.C., Chen, W.G., Pan, A., Pan, C.W., Zhang, Y.H., Qin, L.Q., Chen, L.H., Effect of flaxseed intervention on inflammatory marker C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. Nutrients, 8, 2016, 136.
50. [50] Velalopoulou, A., Tyagi, S., Pietrofesa, R.A., Arguiri, E., Christofidou-Solomidou, M., The flaxseed-derived lignan phenolic Secoisolariciresinol Diglucoside (SDG) protects non-malignant lung cells from radiation damage. Int J Mol Sci, 17, 2016.
51. [51] Pietrofesa, R.A., Velalopoulou, A., Albelda, S.M., Christofidou-Solomidou, M., Asbestos induces oxidative stress and activation of Nrf2 signaling in murine macrophages: chemopreventive role of the synthetic lignan secoisolariciresinol diglucoside (LGM2605). Int J Mol Sci, 17, 2016, 322.
52. [52] Soleas, G.J., Diamandis, E.P., Goldberg, D.M., Resveratrol: a molecule whose time has come? And gone?. Clin Biochem 30 (1997), 91–113.
53. [53] Renaud, S., de Lorgeril, M., Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992), 1523–1526.
54. [54] Liu, Y., He, X.Q., Huang, X., Ding, L., Xu, L., Shen, Y.T., Zhang, F., Zhu, M.B., Xu, B.H., Qi, Z.Q., Wang, H.L., Resveratrol protects mouse oocytes from methylglyoxal-induced oxidative damage. PLoS One, 8, 2013, e77960.
55. [55] Cheng, A.S., Cheng, Y.H., Chiou, C.H., Chang, T.L., Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J Agric Food Chem 60 (2012), 9180–9187.
56. [56] Seo, K., Seo, S., Han, J.Y., Ki, S.H., Shin, S.M., Resveratrol attenuates methylglyoxal-induced mitochondrial dysfunction and apoptosis by Sestrin2 induction. Toxicol Appl Pharmacol 280 (2014), 314–322.
57. [57] Cheng, A.S., Cheng, Y.H., Lee, C.Y., Chung, C.Y., Chang, W.C., Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo. Nutrients 7 (2015), 2850–2865.
58. [58] Khazaei, M., Karimi, J., Sheikh, N., Goodarzi, M.T., Saidijam, M., Khodadadi, I., Moridi, H., Effects of resveratrol on receptor for advanced glycation end products (RAGE) expression and oxidative stress in the liver of rats with type 2 diabetes. Phytother Res 30 (2016), 66–71.
59. [59] Jing, Y.H., Chen, K.H., Yang, S.H., Kuo, P.C., Chen, J.K., Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling. Diabetes Metab Res Rev 26 (2010), 212–222.
60. [60] Moridi, H., Karimi, J., Sheikh, N., Goodarzi, M.T., Saidijam, M., Yadegarazari, R., Khazaei, M., Khodadadi, I., Tavilani, H., Piri, H., Asadi, S., Zarei, S., Rezaei, A., Resveratrol-dependent down-regulation of receptor for advanced glycation end-products and oxidative stress in kidney of rats with diabetes. Int J Endocrinol Metab, 13, 2015, e23542.
61. [61] Ciddi, V., Dodda, D., Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies. Pharmacol Rep 66 (2014), 799–803.
62. [62] Lv, L., Shao, X., Wang, L., Huang, D., Ho, C.T., Sang, S., Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal. J Agric Food Chem 58 (2010), 2239–2245.
63. [63] Li, D., Mitsuhashi, S., Ubukata, M., Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation. Pharm Biol 50 (2012), 1531–1535.
64. [64] Li, X., Zheng, T., Sang, S., Lv, L., Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal. J Agric Food Chem 62 (2014), 12152–12158.
65. [65] Wang, P., Chen, H., Sang, S., Trapping methylglyoxal by genistein and its metabolites in mice. Chem Res Toxicol 29 (2016), 406–414.
66. [66] Zhu, Y., Zhao, Y., Wang, P., Ahmedna, M., Sang, S., Bioactive ginger constituents alleviate protein glycation by trapping methylglyoxal. Chem Res Toxicol 28 (2015), 1842–1849.
67. [67] Sang, S., Shao, X., Bai, N., Lo, C.Y., Yang, C.S., Ho, C.T., Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species. Chem Res Toxicol 20 (2007), 1862–1870.
68. [68] Wu, C.H., Wu, C.F., Huang, H.W., Jao, Y.C., Yen, G.C., Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Mol Nutr Food Res 53 (2009), 984–995.
69. [69] Cai, Q., Li, B.Y., Gao, H.Q., Zhang, J.H., Wang, J.F., Yu, F., Yin, M., Zhang, Z., Grape seed procyanidin b2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products. Biosci Biotechnol Biochem 75 (2011), 1692–1697.
70. [70] Li, B.Y., Li, X.L., Cai, Q., Gao, H.Q., Cheng, M., Zhang, J.H., Wang, J.F., Yu, F., Zhou, R.H., Induction of lactadherin mediates the apoptosis of endothelial cells in response to advanced glycation end products and protective effects of grape seed procyanidin B2 and resveratrol. Apoptosis 16 (2011), 732–745.
71. [71] Wu, Q., Chen, H., Lv, Z., Li, S., Hu, B., Guan, Y., Xie, B., Sun, Z., Oligomeric procyanidins of lotus seedpod inhibits the formation of advanced glycation end-products by scavenging reactive carbonyls. Food Chem 138 (2013), 1493–1502.
72. [72] Shao, X., Chen, H., Zhu, Y., Sedighi, R., Ho, C.T., Sang, S., Essential structural requirements and additive effects for flavonoids to scavenge methylglyoxal. J Agric Food Chem 62 (2014), 3202–3210.